Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres Matoso

Showing results (151-160 of 182) with videos related to

Pageof 19
Sort By:
The American Journal of Surgical Pathology|May 17, 2021
A Novel NIPBL-NACC1 Gene Fusion Is Characteristic of the Cholangioblastic Variant of Intrahepatic CholangiocarcinomaPedram Argani, Doreen N Palsgrove, Robert A Anders, et al.
European Urology Oncology|February 17, 2020
Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression ProfileJean Hoffman-Censits, Woonyoung Choi, Sumanta Pal, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonistPeter K Um, Monali Praharaj, Kara A Lombardo, et al.
Archives of Pathology & Laboratory Medicine|February 17, 2025
Artificial Intelligence-Based Classification of Renal Oncocytic Neoplasms: Advancing From a 2-Class Model of Renal Oncocytoma and Low-Grade Oncocytic Tumor to a 3-Class Model Including Chromophobe Renal Cell CarcinomaKatrina Collins, Shubham Innani, Kingsley Ebare, et al.
European Urology|December 6, 2025
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial CarcinomaEvangelia Vlachou, Burles Avner Johnson, Max Kates, et al.
Nature Communications|March 24, 2026
Retraction Note: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
Nature Communications|February 16, 2022
Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
The American Journal of Surgical Pathology|July 31, 2023
"Oncocytoid Renal Cell Carcinomas After Neuroblastoma" Represent TSC -mutated Eosinophilic Solid and Cystic Renal Cell Carcinomas : Association With Prior Childhood Malignancy and Multifocality With Therapeutic ImplicationsPedram Argani, L Jeffrey Medeiros, Andres Matoso, et al.
Histopathology|August 16, 2022
Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinomaKatrina Collins, Michael Hwang, Tatjana Antic, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2018
Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumorsMichael C Haffner, Diana Taheri, Eddie Luidy-Imada, et al.
Pageof 19

Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
The American Journal of Surgical Pathology|May 17, 2021
A Novel NIPBL-NACC1 Gene Fusion Is Characteristic of the Cholangioblastic Variant of Intrahepatic CholangiocarcinomaPedram Argani, Doreen N Palsgrove, Robert A Anders, et al.
European Urology Oncology|February 17, 2020
Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression ProfileJean Hoffman-Censits, Woonyoung Choi, Sumanta Pal, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonistPeter K Um, Monali Praharaj, Kara A Lombardo, et al.
Archives of Pathology & Laboratory Medicine|February 17, 2025
Artificial Intelligence-Based Classification of Renal Oncocytic Neoplasms: Advancing From a 2-Class Model of Renal Oncocytoma and Low-Grade Oncocytic Tumor to a 3-Class Model Including Chromophobe Renal Cell CarcinomaKatrina Collins, Shubham Innani, Kingsley Ebare, et al.
European Urology|December 6, 2025
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial CarcinomaEvangelia Vlachou, Burles Avner Johnson, Max Kates, et al.
Nature Communications|March 24, 2026
Retraction Note: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
Nature Communications|February 16, 2022
Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
The American Journal of Surgical Pathology|July 31, 2023
"Oncocytoid Renal Cell Carcinomas After Neuroblastoma" Represent TSC -mutated Eosinophilic Solid and Cystic Renal Cell Carcinomas : Association With Prior Childhood Malignancy and Multifocality With Therapeutic ImplicationsPedram Argani, L Jeffrey Medeiros, Andres Matoso, et al.
Histopathology|August 16, 2022
Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinomaKatrina Collins, Michael Hwang, Tatjana Antic, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2018
Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumorsMichael C Haffner, Diana Taheri, Eddie Luidy-Imada, et al.
Pageof 19